BIA
PTCT icon

Bell Investment Advisors’s PTC Therapeutics PTCT Stock Holding History

Bell Investment Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$477 – 1892
2026
Q1 		$477 Buy
+7
New +$496 ﹤0.01% 1762
2023
Q3 		– Sell
-18
Closed -$733 – 1980
2023
Q2 		$733 Hold
18
– – ﹤0.01% 1672
2023
Q1 		$872 Hold
18
– – ﹤0.01% 1623
2022
Q4 		$687 Sell
18
-10
-36% -$416 ﹤0.01% 1687
2022
Q3 		$1K Buy
28
+10
+56% +$490 ﹤0.01% 1534
2022
Q2 		$1K Buy
+18
New +$631 ﹤0.01% 1554
2021
Q4 		$2K Sell
42
-23
-35% -$880 ﹤0.01% 1209
2021
Q3 		$2K Buy
+65
New +$2.67K ﹤0.01% 1134

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bell Investment Advisors's PTCT Position: Q2 2026 in Review

Bell Investment Advisors sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 7 shares — an estimated $477 sold.

Bell Investment Advisors first reported a position in PTCT in Q3 2021 and held it in 8 quarters. The position peaked at $2K in Q4 2021. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Bell Investment Advisors reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Bell Investment Advisors sold 7 PTC Therapeutics shares in Q2 2026, an estimated $477.
  • Bell Investment Advisors first reported a position in PTC Therapeutics in Q3 2021 and held it in 8 quarters.
  • Bell Investment Advisors's PTC Therapeutics position peaked at $2K in Q4 2021.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.